Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Steatohepatitis
NCT07265297Phase 3Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in Nonalcoholic steatohepatitis (NASH), sponsored by National Taiwan University Hospital. Started Aug 2025; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT07265297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265297.